MannKind Corp
NASDAQ:MNKD

Watchlist Manager
MannKind Corp Logo
MannKind Corp
NASDAQ:MNKD
Watchlist
Price: 6.84 USD -0.87% Market Closed
Market Cap: 1.9B USD
Have any thoughts about
MannKind Corp?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

32.9
Current
-16
Median
4.2
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
32.9
=
Enterprise Value
2.1B USD
/
EBITDA
63.7m USD
All Countries
Close
Market Cap EV/EBITDA
US
MannKind Corp
NASDAQ:MNKD
1.9B USD 32.9
FR
Pharnext SCA
OTC:PNEXF
6T USD -219 796.6
US
Abbvie Inc
NYSE:ABBV
312.7B USD 15.3
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 17.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 24
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 9.9
US
Epizyme Inc
F:EPE
94.1B EUR -514.1
AU
CSL Ltd
ASX:CSL
133.6B AUD 20.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 16.2
US
Seagen Inc
F:SGT
39.3B EUR -58.7
NL
argenx SE
XBRU:ARGX
34.5B EUR -104.5
EBITDA Growth
US
MannKind Corp
NASDAQ:MNKD
Average EV/EBITDA: 19.4
32.9
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More